Rom Eliaz

Rom E.
Eliaz is currently the Chief Executive Officer at Olive Diagnostics Ltd. and the Chief Technology Officer at Albaad Ltd. Previously, he held positions such as President & Chief Executive Officer at Imcure Therapeutics, Inc., Chief Executive Officer at SciSparc Ltd., Chief Executive Officer & Managing Director at Elrom Ventures Corp., Chief Executive Officer at IR-Med, Inc., Director-Development at Pfizer Inc., Senior Director-Development at Intradigm Corp., Director at Avanyx Therapeutics, Inc., and Independent Director at Boston Therapeutics, Inc. He also served as an Independent Director at Oxygen Therapy, Inc. and as a Partner at The Colmen Group, Inc. Dr. Eliaz obtained his undergraduate, graduate, and doctorate degrees from Ben-Gurion University of the Negev and his doctorate degree from Weizmann Institute of Science.
He also holds an MBA from Harvard Business School.